Smell test to predict glioblastoma outcomes (newly diagnosed)
Part of Cancer clinical trials.
This study looks at whether a simple smell test can help predict how glioblastoma will progress. It is for people who are newly diagnosed and have not started treatment yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must have a newly diagnosed glioblastoma (a type of brain tumor) that hasn't been treated yet
- You must not have had chemotherapy or radiation to your head or neck before
- You must be able to care for yourself (KPS score of 70 or higher)
- You must not have a current respiratory infection or permanent loss of smell from a past infection
- You must be able to understand and participate in the study without language barriers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a daily smell training routine can help improve your sense of smell. It is open to adults with any kind of smell loss or problem, including those with conditions like COVID-19 or head injury, but not certain brain diseases.
This trial tests whether testing drugs on your tumor cells in a lab can help find the best treatment for you. It is for people with a specific type of glioblastoma that has not been treated yet.
This study uses an EEG (a test that records brain activity) and a special smell stimulus to understand how the brain processes smells in people with smell disorders. It may help researchers learn more about why smell loss happens.
This study tests whether a simple smell test can help predict recovery of consciousness in patients who remain in a coma or minimally conscious state after a severe brain injury. If you or your loved one has been unresponsive for several days after sedation is stopped, this trial may provide useful information about prognosis.
This trial studies how smell testing might affect your health. You'll take part in online sessions where you smell different scents and answer questions.
This trial is testing whether certain details on brain scans can help doctors better predict how brain cancer (glioblastoma) will progress. You may be eligible if you are newly diagnosed with this type of cancer and plan to receive standard treatment.
Hear when a new Glioblastoma Multiforme, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.